Answers are grounded in this paper and cite their sources.
Eukaryotes deploy elaborate defensive systems to protect the structure of their genomes and to oppose the expression of abnormal or alien transcription units. In mammals, the insertion of retroviral DNA or the incorporation of repeat arrays can trigger transcriptional silencing of the inserted sequences, usually via mechanisms that involve methylation of DNA within regulatory regions. Fungi and plants have similar methylation-based systems and also employ diverse post-transcriptional mechanisms to reduce or eliminate the expression of alien transcription units, mechanisms that operate even in organisms that apparently lack the capacity to methylate their DNA. Given their ubiquity in other eukaryotes, it is likely that similar post-transcriptional silencing mechanisms will be found to operate in mammals as well. I argue here that gene silencing mechanisms are diverse and efficient and are likely to represent a barrier to many forms of gene therapy. For this reason, it will be necessary to develop gene therapy vectors that are both resistant to host defensive measures and efficient in terms of delivery and expression.
No takes yet. Share an insight, caveat, or question.
Timothy H. Bestor (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: